Skip to main content

Table 2 Key model building steps and associated objective function changes

From: Covariates of intravenous paracetamol pharmacokinetics in adults

Basic model

OBJ

1-compartment - no size scaling

8350.263

2-compartment - no size scaling

5804.790

3-compartment – no size scaling

5762.275

3-compartment – no size scaling + individual study centre RUV

5210.072

+BOV

5024.826

+BOV + allometric scaling FFM

4956.866

+BOV + allometric scaling TBW

4942.960

+BOV + allometric scaling NFM

4927.983

+BOV + allometric scaling NFM FfatCL = 1

4924.844

+BOV + allometric scaling NFM FfatCL = 0

4946.221

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV

4908.588

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FAGECL

4901.989

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FAGECL + FSEXCL

4900.663

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FAGECL + FPREGCL

-FSEXCL

4893.125

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FAGECL + FPREGCL + FICCL

4888.551

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FAGECL + FPREGCL + FICVOL

-FICCL

4876.427

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FAGECL + FPREGCL + FICV + FHDUCL

4875.677

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FAGECL + FPREGCL + FICV + FORTHOV

-FHDUCL

4839.712

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FAGECL + FPREGCL + FICV + FORTHOV + FABDCL

4827.174

+BOV + allometric scaling NFM FfatCL = 1 + FAGEV + FPREGCL + FICV + FORTHOV + FABDCL

-FAGECL

4827.284

  1. An OBJ decrease of 6.635 (p < 0.01) for these nested models was deemed significant for covariate inclusion.
  2. [BOV = between occasion variability; RUV = residual unexplained variability; FFM = fat free mass; TBW = total body weight; NFM = normal fat mass; CL = clearance; abd = abdominal surgery; preg = pregnant; IC = intensive care; HD = high dependency care; ortho = orthopaedic surgery].